EFFECTS OF N-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE AND ITS METABOLITE, N-METHYL-4-PHENYLPYRIDINIUM ION, ON DOPAMINERGIC NIGROSTRIATAL NEURONS IN THE MOUSE
EFFECTS OF N-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE AND ITS METABOLITE, N-METHYL-4-PHENYLPYRIDINIUM ION, ON DOPAMINERGIC NIGROSTRIATAL NEURONS IN THE MOUSE
复制标题
DOI:
10.1016/0304-3940(85)90074-6
复制
发表时间:
1985-01-01
影响因子:
2.5
通讯作者:
WRIGHT, JM
中科院分区:
文献类型:
--
作者:
PERRY, TL;YONG, VW;WRIGHT, JM
A single subcutaneous injection in the C57 black mouse of 40 mg/kg of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) causes a 90% depletion of striatal dopamine, as well as loss of 33% of neuronal cell bodies in the substantia nigra, zona compacta. By 4.5 months, there appears to be partial recovery of striatal dopaminergic function. After injection into mice, the MPTP metabolite, N-methyl-4-phenylpyridinium ion (MPP+) enters the striatum, and through some unknown mechanism is even more toxic than MPTP. However, repeated injections of maximally tolerated amounts of MPP+ do not damage dopaminergic nigrostriatal neurons.